PTEN deletion drives aberrations of DNA methylome and transcriptome in different stages of prostate cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PTEN deletion drives aberrations of DNA methylome and transcriptome in different stages of prostate cancer
Authors
Keywords
-
Journal
FASEB JOURNAL
Volume -, Issue -, Pages -
Publisher
FASEB
Online
2019-11-29
DOI
10.1096/fj.201901205rr
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heritable methylation marks associated with breast and prostate cancer risk
- (2018) Pierre-Antoine Dugué et al. PROSTATE
- CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-κB/SOX4 signaling
- (2018) Neng Wang et al. Cell Death & Disease
- PTEN loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profiles
- (2017) Milan S. Geybels et al. Oncotarget
- Methylation profiling identified novel differentially methylated markers includingOPCMLandFLRT2in prostate cancer
- (2016) Yu Wu et al. Epigenetics
- Promoter Methylation of PTEN Is a Significant Prognostic Factor in Melanoma Survival
- (2016) Mi Ryung Roh et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells
- (2016) Sarandeep S.S. Boyanapalli et al. PHARMACOLOGICAL RESEARCH
- CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment
- (2016) Tao Zhang et al. Nature Communications
- Epigenetic modulators as therapeutic targets in prostate cancer
- (2016) Inês Graça et al. Clinical Epigenetics
- Persistent Inflammation Leads to Proliferative Neoplasia and Loss of Smooth Muscle Cells in a Prostate Tumor Model
- (2015) Andreas Birbach et al. NEOPLASIA
- HTSeq--a Python framework to work with high-throughput sequencing data
- (2014) S. Anders et al. BIOINFORMATICS
- Epigenetic DNA Methylation of Antioxidative Stress Regulator NRF2 in Human Prostate Cancer
- (2014) T. O. Khor et al. Cancer Prevention Research
- Pten Null Prostate Epithelium Promotes Localized Myeloid-Derived Suppressor Cell Expansion and Immune Suppression during Tumor Initiation and Progression
- (2014) A. J. Garcia et al. MOLECULAR AND CELLULAR BIOLOGY
- Methylation analysis of the phosphates and tensin homologue on chromosome 10 gene (PTEN) in multiple myeloma
- (2014) Giovanna Piras et al. Clinical Epigenetics
- Epigenetic Reactivation of Nrf2 in Murine Prostate Cancer TRAMP C1 Cells by Natural Phytochemicals Z-Ligustilide and Radix Angelica Sinensis via Promoter CpG Demethylation
- (2013) Zheng-Yuan Su et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Clinical significance of both tumor and stromal expression of components of the IL-1 and TNF-α signaling pathways in prostate cancer
- (2013) Gonzalo Rodríguez-Berriguete et al. CYTOKINE
- Characterization of interleukin-1β in Helicobacter pylori-induced gastric inflammation and DNA methylation in interleukin-1 receptor type 1 knockout (IL-1R1−/−) mice
- (2013) Fung-Yu Huang et al. EUROPEAN JOURNAL OF CANCER
- Chemokine (C-X-C motif) ligand 1 (CXCL1) protein expression is increased in high-grade prostate cancer
- (2013) Makito Miyake et al. PATHOLOGY RESEARCH AND PRACTICE
- TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions
- (2013) Daehwan Kim et al. GENOME BIOLOGY
- Variation in IL10 and Other Genes Involved in the Immune Response and in Oxidation and Prostate Cancer Recurrence
- (2012) P. J. Dluzniewski et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Inflammation, DNA methylation and colitis-associated cancer
- (2012) L. Hartnett et al. CARCINOGENESIS
- A DNA methylation signature associated with aberrant promoter DNA hypermethylation of DNMT3B in human colorectal cancer
- (2012) Covadonga Huidobro et al. EUROPEAN JOURNAL OF CANCER
- Potentiation of Inflammatory CXCL8 Signalling Sustains Cell Survival in PTEN-deficient Prostate Carcinoma
- (2012) Pamela J. Maxwell et al. EUROPEAN UROLOGY
- A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff
- (2012) Pablo Cingolani et al. FLY
- Mucosal genome-wide methylation changes in inflammatory bowel disease
- (2012) James Cooke et al. INFLAMMATORY BOWEL DISEASES
- Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis
- (2012) Thomas Jamieson et al. JOURNAL OF CLINICAL INVESTIGATION
- Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications
- (2011) Felix Krueger et al. BIOINFORMATICS
- Epigenetics in Prostate Cancer: Biologic and Clinical Relevance
- (2011) Carmen Jerónimo et al. EUROPEAN UROLOGY
- The Controversial Relationship Between Benign Prostatic Hyperplasia and Prostate Cancer: The Role of Inflammation
- (2011) Cosimo De Nunzio et al. EUROPEAN UROLOGY
- c-Myb and GATA-3 Cooperatively Regulate IL-13 Expression via Conserved GATA-3 Response Element and Recruit Mixed Lineage Leukemia (MLL) for Histone Modification of the IL-13 Locus
- (2011) T. Kozuka et al. JOURNAL OF IMMUNOLOGY
- MYC Cooperates with AKT in Prostate Tumorigenesis and Alters Sensitivity to mTOR Inhibitors
- (2011) Nicola J. Clegg et al. PLoS One
- BEDTools: a flexible suite of utilities for comparing genomic features
- (2010) Aaron R. Quinlan et al. BIOINFORMATICS
- Epigenetic Mechanisms of Promigratory Chemokine CXCL14 Regulation in Human Prostate Cancer Cells
- (2010) Eun Young Song et al. CANCER RESEARCH
- Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formation
- (2010) Seth B. Furgeson et al. CARDIOVASCULAR RESEARCH
- Nrf2 Expression Is Regulated by Epigenetic Mechanisms in Prostate Cancer of TRAMP Mice
- (2010) Siwang Yu et al. PLoS One
- The context and potential of epigenetics in oncology
- (2009) J Lopez et al. BRITISH JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started